OncoHost Wins Gold for AI-Powered Cancer Prediction Platform

Jerusalem, 4 December, 2025 (TPS-IL) — Israeli–US precision oncology firm OncoHost announced Thursday it has been named a Gold Winner in the 2025 Merit Awards for Healthcare, earning the title of Technology Solution of the Year. Headquartered in Binyamina and Cary, North Carolina, the company was recognized for its PROphet platform, an AI-driven proteomics tool that predicts patient response to cancer therapies from a single blood sample.

CEO Dr. Ofer Sharon said the award underscores the platform’s clinical value in guiding oncologists toward more informed treatment decisions. OncoHost is expanding PROphet to additional cancers, including renal cell carcinoma and melanoma, as it builds its global footprint in precision oncology.